Immunogenicity and Safety of the New Inactivated Quadrivalent Influenza Vaccine Vaxigrip Tetra: Preliminary Results in Children ≥6 Months and Older Adults

By Montomoli Emanuele   Torelli Alessandro   Manini Ilaria   Gianchecchi Elena  

Vaccines, Vol. 6, Iss. 1, 2018-03 ,pp. : 14-14

MDPI

Access to resources Recommend Favorite

Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy Adults

By Chichester Jessica A.   Jones R. Mark   Green Brian J.   Stow Mark   Miao Fudu   Moonsammy George   Streatfield Stephen J.   Yusibov Vidadi  

Viruses, Vol. 4, Iss. 11, 2012-11 ,pp. : 3227-3244

MDPI

Access to resources Recommend Favorite

Thimerosal-Preserved Hepatitis B Vaccine and Hyperkinetic Syndrome of Childhood

By Geier David A.   Kern Janet K.   Hooker Brian S.   Sykes Lisa K.   Geier Mark R.  

Brain Sciences, Vol. 6, Iss. 1, 2016-03 ,pp. : 9-9

MDPI

Access to resources Recommend Favorite

Hepatitis B At-Birth Dose Vaccine: An Urgent Call for Implementation in Ghana

By Awuku Yaw Asante   Yeboah-Afihene Mary  

Vaccines, Vol. 6, Iss. 1, 2018-03 ,pp. : 15-15

MDPI

Access to resources Recommend Favorite

Immunogenicity and Safety of Pandemic Influenza H5N1 Vaccines in Healthy Adults through Meta-Analysis

By  

Cellular Physiology and Biochemistry, Vol. 40, Iss. 5, 2016-12 ,pp. : 921-932

Karger

Access to resources Recommend Favorite